🎗️ OncologyInjection (IV)
Abecma
Idecabtagene Vicleucel
BCMA-directed CAR T-cell therapy for relapsed/refractory multiple myeloma after multiple prior lines.
Form
Injection (IV)
Uses
1
Side effects
5
Category
Oncology
01
What is Abecma used for?
- Relapsed/refractory multiple myeloma
02
Idecabtagene Vicleucel side effects
Common side effects of Idecabtagene Vicleucel include:
Cytokine release syndrome
Neurotoxicity
Infections
Cytopenias
Hypogammaglobulinemia
CommonModerateLess common
03
Idecabtagene Vicleucel warnings & precautions
- Black box: CRS, neurological toxicity, HLH, prolonged cytopenias, secondary T-cell malignancies
- REMS required
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Abecma in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.